Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response Pharmacogenetic Study of ADHD
NCT00663442Phase 4Completed
- Sponsor
- University of Illinois Chicago
- Start
- Dec 1999
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Illinois Chicago. Started Dec 1999; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00663442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663442.